✦ LIBER ✦

Drug Trial in Women With Progressing Advanced Breast Cancer Presented

✍ Scribed by Cockey, Carolyn Davis

Book ID: 109266152
Publisher: John Wiley and Sons
Year: 2003
Weight: 141 KB
Volume: 7
Category: Article
ISSN: 1091-5923
DOI: 10.1111/j.1552-6356.2003.tb00359.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hyperhomocysteinemia in women with advan

Hyperhomocysteinemia in women with advanced breast cancer

✍ A. GATT; A. MAKRIS; H. CLADD; R. J. BURCOMBE; J. M. SMITH; P. COOPER; D. THOMPSO 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Clinical Trial of Letrozole (femara) ver

Clinical Trial of Letrozole (femara) versus Aminoglutethimide in Postmenopausal Women with Advanced Breast Cancer

✍ Xiaoqing LIU; Santai SONG; Zefei JIANG; Weilian LI; Weixia WANG; Hui YANG 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 84 KB

A randomised trial of tamoxifen versus t

A randomised trial of tamoxifen versus tamoxifen with aminoglutethimide in post-menopausal women with advanced breast cancer

✍ R. Milsted; T. Habeshaw; S. Kaye; G. Sangster; F. Macbeth; J. Campbell-Ferguson; 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 182 KB

Clinical trial of nafoxidine in adrenale

Clinical trial of nafoxidine in adrenalectomized patients with advanced breast cancer

✍ Jitender Jain; Bohumil Samal; Amnuay Singhakowinta; V. K. Vaitkevicius 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

Impact of breast surgery on survival in

Impact of breast surgery on survival in women presenting with metastatic breast cancer

✍ N. Bhoo Pathy; H. M. Verkooijen; N. A. Taib; M. Hartman; C. H. Yip 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 3 views

Use of aromatase inhibitors in postmenop

Use of aromatase inhibitors in postmenopausal women with advanced breast cancer

✍ Roseman, Barry J.; Buzdar, Aman U.; Singletary, S. Eva 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 2 views

Surgeons have been involved in the management of metastatic breast cancer since the technique of ovarian ablation was introduced in 1896. However, as newer hormonal and chemotherapeutic regimens were developed, drug therapy gradually replaced surgery as the preferred treatment for metastatic breast